Tags:Content DistributionDiagnosticsHardwareManufacturingMedTechPlatformProductSalesServiceTechnology
Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists diagnosing and treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 25 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®).
Location: United States, Georgia, Roswell
Member count: 201-500
Total raised: $57M
Founded date: 2008

Investors 3

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
05.03.2015-$57M-massdevice...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
01.11.2016Watch 5 st...The Philadelphia Alliance for ...--technical....
06.05.2015EndoChoice...EndoChoice said today that it ...-Brad Perri...massdevice...
06.03.2015Funding ro...Nextdoor, YouMail, RockYou, Te...-Steven Loe...vator.tv/n...
05.03.2015EndoChoice...EndoChoice, an Atlanta GA area...USA-finsmes.co...
05.03.2015EndoChoice...EndoChoice today said it raise...-Brad Perri...massdevice...
31.10.2013EndoChoice...From the press release: Becau...--medcitynew...
10.01.2013EndoChoice...In a flurry of moves starting ...-MassDevice...massdevice...
-EndoChoice...EndoChoice, an Atlanta, Ga.-ba...--medcitynew...